Levine, Arnold J. http://orcid.org/0000-0002-1871-6387
Carpten, John D.
Murphy, Maureen
Hainaut, Pierre http://orcid.org/0000-0002-1303-1610
Article History
Received: 2 August 2023
Revised: 8 October 2023
Accepted: 30 October 2023
First Online: 24 November 2023
Competing interests
: AJL is a founder, Board member and share holder in a Biotech company, PMV, that synthesizes small molecules that reactivate a mutant p53 mutation, restoring its wild- type function. He consults for Pharmabody, a monoclonal antibody company in Singapore and Chugai pharmaceutical company. The other authors have no competing interests.